Abstract
Allogeneic CAR-T PBCAR0191 with Intensified Lymphodepletion Is Highly Active in Patients with Relapsed/Refractory B-Cell Malignancies
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have